Midterm Outcomes in a Pooled Cohort of Harmony Transcatheter Pulmonary Valve Recipients
Circulation: Cardiovascular Interventions · 2025
DOI: 10.1161/circinterventions.125.015196 ↗Kurz gefasst
Kontrollierte klinische Studie in der Zeitschrift Circulation: Cardiovascular Interventions, 2025. Verfasst von Brian H Morray und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Cardiology, Seattle Children's Hospital, WA (B.H.M., T.K.J.). Hauptthemen laut MEDLINE: Cardiac Catheterization, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation, Pulmonary Valve. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: The Harmony transcatheter pulmonary valve (TPV) is designed to treat severe pulmonary regurgitation in the native or surgically repaired right ventricular (RV) outflow tract. Early outcomes after TPV replacement with the Harmony valve have been positive, but longer-term data are limited. METHODS: The study included patients who received a commercially available TPV22 or TPV25 device as part of the nonrandomized, prospective Native Outflow Tract Early Feasibility Study, Harmony Pivotal Trial, and Continued Access Study. Patients completed at least 3 years of follow-up, and outcomes to 5 years were reported when available. RESULTS: Eighty-nine patients were catheterized, and 86 were successfully implanted with a Harmony TPV. Median duration of follow-up was 5 (range 0–6) years in the TPV22 group and 3 (1–4) years in the TPV25 group. At 3 years, all patients with a TPV22 and 96% of those with a TPV25 had ≤mild pulmonary regurgitation. By magnetic resonance imaging, significant improvements from preimplant to 2 years were observed in RV end-diastolic volume index, RV to left ventricular end-diastolic volume ratio, and effective RV stroke volume (all P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pediatric Cardiology, Seattle Children's Hospital, WA (B.H.M., T.K.J.).
- Division of Cardiology, Children's Hospital of Philadelphia, PA (M.J.G.).
- Pediatrics and Cardiology, The Ohio State University, Columbus (J.P.C.).
- Nationwide Children's Hospital, Columbus, OH (A.S.).
- Department of Pediatrics, Stanford University, Lucile Packard Children's Hospital, Palo Alto, CA (L.P.).
- Department of Pediatrics, David Geffen School of Medicine at UCLA, Ahmanson/UCLA Adult Congenital Heart Disease Center, Los Angeles, CA (D.S.L.).
ORCID-Profile: Brian H Morray, John P Cheatham, Arash Salavitabar, Thomas K Jones, Daniel S Levi, Jeremy Asnes, Allison K Cabalka, Kazuto Fujimoto, Athar M Qureshi, Lee N Benson, Doff B McElhinney
Zitieren
APA
Morray, B. H., Gillespie, M. J., Cheatham, J. P., Salavitabar, A., Peng, L., Jones, T. K., Levi, D. S., Gray, R. G., Asnes, J., Cabalka, A. K., Fujimoto, K., Qureshi, A. M., Bergersen, L., Benson, L. N., Haugan, D., & McElhinney, D. B. (2025). Midterm Outcomes in a Pooled Cohort of Harmony Transcatheter Pulmonary Valve Recipients. Circulation: Cardiovascular Interventions. https://doi.org/10.1161/circinterventions.125.015196
Vancouver
Morray BH, Gillespie MJ, Cheatham JP, Salavitabar A, Peng L, Jones TK, et al. Midterm Outcomes in a Pooled Cohort of Harmony Transcatheter Pulmonary Valve Recipients. Circulation: Cardiovascular Interventions. 2025. doi:10.1161/circinterventions.125.015196
BibTeX
@article{Morray2025,
author = {Morray, Brian H and Gillespie, Matthew J and Cheatham, John P and Salavitabar, Arash and Peng, Lynn and Jones, Thomas K and Levi, Daniel S and Gray, Robert G and Asnes, Jeremy and Cabalka, Allison K and Fujimoto, Kazuto and Qureshi, Athar M and Bergersen, Lisa and Benson, Lee N and Haugan, Daniel and McElhinney, Doff B},
title = {Midterm Outcomes in a Pooled Cohort of Harmony Transcatheter Pulmonary Valve Recipients},
journal = {Circulation: Cardiovascular Interventions},
year = {2025},
doi = {10.1161/circinterventions.125.015196}
}
EUVIMED